Longterm Effects of Expectations on Mood
NCT03607214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2019-08-16
Summary
The study tries to identify whether positive expectations, induced with a placebo nasal-spray, have short- and longterm effects on participant's mood.
Conditions
- Healthy Participants
Interventions
- OTHER
-
Placebo
Placebo nasal spray Film Sequence
Sponsors & Collaborators
-
Philipps University Marburg
lead OTHER
Principal Investigators
-
Winfried Rief, Professor · Philipps-Univeristy of Marburg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2019-04-15
- Completion
- 2019-05-15
Countries
- Germany
Study Locations
More Related Trials
-
Duloxetine vs Placebo in the Treatment of General Anxiety
NCT00475969 ·Status: COMPLETED ·Phase: PHASE3
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
NCT00658762 ·Status: TERMINATED ·Phase: PHASE3
-
Brief Group Psychotherapy for Anxiety and Depression
NCT04489641 ·Status: COMPLETED ·Phase: NA
-
Expectation of Unpleasant Events in Anxiety Disorders
NCT00055224 ·Status: COMPLETED ·Phase: NA
-
A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
NCT00542685 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacological Modulation of Belief Salience
NCT03754062 ·Status: COMPLETED ·Phase: PHASE1
-
Duloxetine for the Treatment of Generalized Anxiety Disorder
NCT00803361 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Open-label Placebos on COVID-related Psychological Health
NCT05035550 ·Status: COMPLETED ·Phase: NA
-
Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety
NCT04250571 ·Status: COMPLETED ·Phase: NA
-
Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation
NCT05232032 ·Status: RECRUITING ·Phase: PHASE2
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
NCT00658372 ·Status: TERMINATED ·Phase: PHASE3
-
Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
NCT00183274 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
NCT00748956 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
NCT00470483 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
NCT00371176 ·Status: COMPLETED ·Phase: NA
-
Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
NCT02153944 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
NCT04663672 ·Status: COMPLETED ·Phase: NA
-
Neurobiology of Generalized Fear-Conditioning & Avoidance in Anxiety Disorders
NCT03033056 ·Status: COMPLETED
-
Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
NCT01376271 ·Status: COMPLETED
-
Evaluation of the Specialized Clinic for Nutrition and Mental Health: A Pilot Study
NCT07050342 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers
NCT01826786 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Verbal Instructions on Fear Extinction and Extinction Retrieval
NCT05718271 ·Status: COMPLETED ·Phase: NA
-
Identifying Decision Making Parameters in Healthy Volunteers and Anxiety Patients
NCT05092971 ·Status: COMPLETED ·Phase: NA
-
Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
NCT00114127 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety
NCT03085654 ·Status: COMPLETED ·Phase: EARLY_PHASE1